Pressmeddelanden från Neola Medical

Bevaka pressreleaser

Kurs från TradingView

Start Nyheter Pressreleaser Riktkurser Insynshandel Blankning Analyser Bloggar Videos Podcasts

Neola Medical Completes Enrollment in Swedish Clinical Pilot Study 12 feb 07:00

Neola Medical Q4 Report 2025 – Advancing IP Protection as a Core Strategic Asset across Key Markets 05 feb 08:00

Neola Medical invites to presentation of the Q4-report 2025 21 jan 08:15

Valberedning utsedd i Neola Medical AB (publ)17 dec 2025 11:40

Neola Medical’s CEO shares recent company highlights in winter 2025 investor letter 09 dec 2025 07:00

Neola Medical expands leadership team with appointment of Director Disposable Product Development 02 dec 2025 07:00

Neola Medical granted U.S. patent for disposable probes, strengthening future revenue model in target market 13 nov 2025 07:00

Neola Medical granted Patent in China for reducing optical noise in lung monitoring measurements 04 nov 2025 18:57

Neola Medical Q3 Report 2025 – Progressing toward completion of Swedish clinical pilot study and strengthening leadership team 04 nov 2025 18:53

Revised Timeline Announced as Clinical Pilot Study Indicates Robust Safety and Need for Optimization of Neola®16 okt 2025 08:00

Neola Medical Strengthens Global IP Portfolio with New Patents Granted in both the U.S. and China for Medical Device Neola®01 okt 2025 07:00

Neola Medical’s CEO highlights recent progress in autumn 2025 investor letter 25 sep 2025 07:20

Neola Medical strengthens leadership team with appointment of Clinical Director 10 sep 2025 07:00

Neola Medical granted European patent enabling lung monitoring beyond preterm born babies 25 aug 2025 07:55

Neola Medical Q2 Report 2025 – First U.S. Clinical Study Site Agreement Signed, Key Step in Regulatory Path to Market Authorization 18 aug 2025 07:00

Neola Medical invites to presentation of the Q2-report 2025 16 jun 2025 11:00

Neola Medical’s CEO shares clinical progress and recent milestones in summer 2025 investor letter 10 jun 2025 07:00

Neola Medical Signs Agreement with Leading U.S. Hospital for Pivotal Clinical Study on Preterm Born Babies Following IRB Approval 21 maj 2025 17:30

Kommuniké från årsstämma i Neola Medical AB den 21 maj 2025 21 maj 2025 08:45

Neola Medical Q1 Report 2025 – Strengthened shareholder base with institutional investors ahead of clinical study start 21 maj 2025 07:00

First Patient Enrolled in Clinical Pilot Study with Neola® on Preterm Born Babies 08 maj 2025 07:15

Neola Medical Granted European Patent for Lung Monitoring, Strengthens Protection in Key Markets 22 apr 2025 12:30

Neola Medical named finalist for Sweden’s new global innovation award at World Expo 2025 in Japan 10 apr 2025 07:00

KALLELSE TILL ÅRSSTÄMMA I NEOLA MEDICAL AB 09 apr 2025 11:45

Neola Medical AB Publishes 2024 Annual Report 01 apr 2025 07:45

Neola Medical’s CEO shares spring milestones and strengthened shareholder base in 2025 investor letter 25 mar 2025 07:00

Neola Medical Signs Agreement with Södra Älvsborgs Sjukhus in Borås to Initiate Clinical Pilot Study on Preterm Born Babies 12 mar 2025 19:44

Neola Medical har genomfört en riktad emission av aktier om cirka 20 MSEK 12 mar 2025 17:31

Neola Medical avser att genomföra en riktad emission av aktier om cirka 20 MSEK 05 mar 2025 07:00

Neola Medical Granted New Patent Family in China, Protection for Lung Monitoring 12 feb 2025 07:45

Neola Medical Q4 Report 2024 – Received approval for initiation of first clinical pilot study on preterm born babies 11 feb 2025 07:00

Neola Medical receives approval by Swedish Authorities to initiate Clinical Pilot Study on Preterm Born Babies in Sweden 05 feb 2025 07:00

Neola Medical invites to presentation of the Q4-report 2024 04 feb 2025 07:00

Valberedning utsedd i Neola Medical AB (publ)09 jan 2025 07:00

Neola Medical to Participate in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco 18 dec 2024 07:00

Neola Medical’s CEO shares 2024 achievements in Winter Investor Letter 28 nov 2024 07:00

Neola Medical to present at Redeye Technology & Life Science Day 20 nov 2024 07:00

Neola Medical Live at Stora Aktiedagarna in Stockholm: Showcases Strategic Advancements for Market Launch in the U.S.19 nov 2024 07:00

Neola Medical secures U.S. trademark of Neola® logo ahead of market launch 07 nov 2024 07:00

Neola Medical to present at Redeye MedTech & Diagnostics Event 06 nov 2024 07:00

Neola Medical Q3 Report 2024 – Intensifying preparations for the first pivotal clinical study on preterm born babies in the U.S. to secure market approval by the FDA 30 okt 2024 07:00

Neola Medical invites to presentation of the Q3-report 2024 01 okt 2024 07:00

Neola Medical’s CEO highlights recent steps toward market approval in the Autumn 2024 Investor Letter 18 sep 2024 07:00

Neola Medical Showcases GASMAS Technology at Prestigious Neonatal Medicine Congress with Lecture by Leading U.S. Professor in Neonatology 10 sep 2024 07:00

Neola Medical presenting at Medicon Valley Alliance: Our Journey, Their Future.28 aug 2024 08:15

BioStock: New CFO at Neola Medical 28 aug 2024 08:15

BioStock: Ny CFO på Neola Medical 28 aug 2024 07:00

Neola Medical Granted Patent in the USA 26 aug 2024 08:15

Neola’s CEO to BioStock: “We are now preparing for a clinical study in the US”26 aug 2024 08:15

Neolas vd till BioStock: “Nu förbereder vi för klinisk studie i USA”21 aug 2024 08:00

Neola Medical prepares for pivotal clinical study on preterm born babies in the USA 16 aug 2024 08:15

BioStock: CB-certifikat lyfte Neola Medicals Q2 15 aug 2024 07:00

Neola Medical Q2 Report 2024 – Key milestones meet partial regulatory requirements for FDA approval 07 aug 2024 07:00

Neola Medical Granted Patent in Europe, Expands Protection for Medical Device Neola®06 aug 2024 13:50

Neola Medical invites to presentation of the Q2-report 2024 18 jun 2024 08:50

Neola Medical's CEO Announces Key Achievements in the Summer 2024 Investor Letter 05 jun 2024 11:43

Neola’s CEO to BioStock: “The certificate is a clear sign of strength”05 jun 2024 11:43

Neolas vd till BioStock: ”Certifikatet är ett tydligt styrkebesked”04 jun 2024 07:00

Neola® erhåller CB certifikat och uppfyller del av regulatoriska krav inför marknadsgodkännande i USA 31 maj 2024 10:15

Ny CFO på Neola Medical inför marknadslansering i USA 22 maj 2024 16:55

Kommuniké från årsstämma i Neola Medical AB den 22 maj 2024 22 maj 2024 12:39

BioStock: Framgångsrik användbarhetsstudie av Neola Medical 22 maj 2024 06:58

Neola Medical Q1 rapport 2024 – Framgångsrik studie i USA inför regulatoriskt godkännande av Neola®14 maj 2024 07:00

Cardeons samtliga aktier i Neola Medical förvärvas av storägare 22 apr 2024 07:45

Neolas vd till BioStock: “Resultaten från användbarhetstudien bekräftar vår produkt”22 apr 2024 07:45

Neola’s CEO to BioStock: “The results from the usability study confirm our product”18 apr 2024 07:00

Framgångsrika resultat i avslutad användbarhetsstudie med Neola® i USA 10 apr 2024 07:00

KALLELSE TILL ÅRSSTÄMMA I NEOLA MEDICAL AB 09 apr 2024 07:00

Neola Medical AB publicerar årsredovisning för 2023 28 mar 2024 07:00

Neola® får silvermedalj och vinner 25 000 USD i Stanford Pediatric Device Consortium (PDC) Accelerator Pitch Competition 2024 20 mar 2024 07:00

Neola Medicals CEO berättar mer om de senaste nyheterna i vårens investerarbrev 13 mar 2024 09:15

Biostock: Varför vill alla till USA? | Health & Wealth #5 05 mar 2024 09:45

BioStock: Neola initiates usability study ahead of FDA approval 05 mar 2024 09:45

BioStock: Neola startar användbarhetsstudie inför FDA-godkännande 29 feb 2024 07:00

Neola Medical startar användbarhetsstudie i USA inför FDA-ansökan för marknadsgodkännande 15 feb 2024 10:33

Neola Medical summerar 2023 – BioStock kommenterar utvecklingen 14 feb 2024 08:00

Neola Medical Bokslutskommuniké 2023 – Med stärkt kassa levereras ännu ett styrkebesked genom patentskydd för kommande lönsamhetsdrivare 05 feb 2024 11:05

Neola Medical bjuder in till presentation av bokslutskommuniké 2023 24 jan 2024 07:00

Valberedning utsedd i Neola Medical AB (publ)17 jan 2024 08:15

BioStock: Neolas snabba utveckling uppmärksammas på JPMorgan 17 jan 2024 08:15

BioStock: Neola’s rapid development recognised at JPMorgan 08 jan 2024 07:00

CEO Hanna Sjöström deltar vid J.P. Morgan Healthcare Conference i San Francisco för möten med investerare och industripartners 29 dec 2023 15:20

Kommuniké från extra bolagsstämma i Neola Medical AB den 29 december 2023 21 dec 2023 10:49

BioStock Health & Wealth med Hanna Sjöström, Neola Medical 20 dec 2023 07:45

BioStock: Nytt europeiskt patent för Neola Medicals engångsartiklar 20 dec 2023 07:45

BioStock: New European patent for Neola Medical’s disposables 19 dec 2023 12:25

Neola Medicals CEO berättar mer om de senaste nyheterna i vinterns investerarbrev 14 dec 2023 10:45

BioStock: Premie i Neola Medicals riktade emission 14 dec 2023 10:45

BioStock: Premium in Neola Medical’s directed issue 13 dec 2023 08:30

KALLELSE TILL EXTRA BOLAGSSTÄMMA I NEOLA MEDICAL AB 13 dec 2023 08:25

Neola Medical genomför en riktad nyemission om 20 MSEK och säkrar därmed finansiering för 2024 12 dec 2023 11:00

Neola Medical beviljas patent i Europa för bolagets engångsartiklar 04 dec 2023 07:00

Neola Medical AB startar dotterbolag i USA 15 nov 2023 10:45

Neola Medicals CEO berättar mer om de senaste nyheterna i höstens investerarbrev 14 nov 2023 08:45

BioStock: Neolas vd: ”Dörrarna öppnas för oss i USA”14 nov 2023 08:45

BioStock: Neola’s CEO: “The doors open for us in the US”09 nov 2023 07:55

Neola Medical Q3 rapport 2023 – Dörrarna öppnas i USA med stöd från Stanford och nya starka slutresultat från oberoende klinisk studie på nyfödda barn 02 nov 2023 06:35

Neola Medical bjuder in till presentation av Q3-rapport 2023 16 okt 2023 08:45

BioStock: Neola Medical får stöd av Stanford 13 okt 2023 08:15

BioStock: Positiva resultat för Neola presenteras vid framstående konferens